Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectivenessThomas R. E. Barnes, Tim Amos, David Osborn et al.|Health Technology Assessment|2017Cited by 38
Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trialThomas R. E. Barnes, Tim Amos, Verity C. Leeson et al.|Therapeutic Advances in Psychopharmacology|2018Cited by 20
SU11. Amisulpride Augmentation of Clozapine for Treatment-Refractory Schizophrenia: The AMICUS StudyThomas R. E. Barnes, Tim Amos, Verity C. Leeson et al.|Schizophrenia Bulletin|2017Cited by 3